Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

2.55USD
18 Jun 2018
Change (% chg)

$0.02 (+0.79%)
Prev Close
$2.53
Open
$2.55
Day's High
$2.55
Day's Low
$2.55
Volume
200
Avg. Vol
2,932
52-wk High
$4.21
52-wk Low
$2.24

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.19
Market Cap(Mil.): $39.37
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 84.11 32.75
EPS (TTM): -0.66 -- --
ROI: -119.26 1.56 14.38
ROE: -119.07 2.43 16.07

BRIEF-Cleveland Biolabs Says Received Formal Notification From EMA

* CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM EMA REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD

28 Mar 2018

BRIEF-Cleveland Biolabs Reports Qtrly Loss Per Share $0.10‍​

* CLEVELAND BIOLABS-ESTIMATES CASH,CASH EQUIVALENTS,SHORT-TERM INVESTMENTS AS OF DEC 31 ENOUGH TO FUND OPERATIONS FOR AT LEAST 1 YEAR AFTER 10-K FILING DATE Source text: (http://bit.ly/2FXHEdA) Further company coverage:

06 Mar 2018

Earnings vs. Estimates